In vivo monoclonal antibody treatment with Ox19 (anti-rat CD5) causes disease relapse and terminates P2-induced immunospecific tolerance in experimental allergic neuritis
K. Strigård, P. Larsson, R. Holmdahl, L. Klareskog, T. OlssonVolume:
23
Year:
1989
Language:
english
DOI:
10.1016/0165-5728(89)90066-0
File:
PDF, 907 KB
english, 1989